A detailed history of Lombard Odier Asset Management (Switzerland) Sa transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lombard Odier Asset Management (Switzerland) Sa holds 54,389 shares of BMY stock, worth $3.14 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
54,389
Previous 47,414 14.71%
Holding current value
$3.14 Million
Previous $1.97 Million 42.92%
% of portfolio
0.25%
Previous 0.2%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $276,628 - $360,956
6,975 Added 14.71%
54,389 $2.81 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $479,498 - $631,269
-11,913 Reduced 20.08%
47,414 $1.97 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $1.51 Million - $1.71 Million
31,418 Added 112.57%
59,327 $3.22 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $500,119 - $596,780
10,316 Added 58.64%
27,909 $1.43 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $89,613 - $100,202
-1,548 Reduced 8.09%
17,593 $1.02 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $13.7 Million - $15.2 Million
-215,121 Reduced 91.83%
19,141 $1.22 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $589,484 - $668,608
-8,971 Reduced 3.69%
234,262 $16.2 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $3.09 Million - $3.66 Million
-45,161 Reduced 15.66%
243,233 $17.5 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $680 - $402,411
-5,237 Reduced 1.78%
288,394 $20.5 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $4.7 Million - $5.17 Million
-64,667 Reduced 18.05%
293,631 $22.6 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $20.8 Million - $24.9 Million
337,756 Added 1644.22%
358,298 $26.2 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $261,338 - $304,659
-4,873 Reduced 19.17%
20,542 $1.28 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $23,253 - $27,238
-393 Reduced 1.52%
25,415 $1.41 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $396,285 - $431,555
6,401 Added 32.98%
25,808 $1.72 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $207,393 - $233,256
-3,495 Reduced 15.26%
19,407 $1.23 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $1.27 Million - $1.43 Million
-21,917 Reduced 48.9%
22,902 $1.42 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $947,135 - $1.05 Million
16,492 Added 58.22%
44,819 $2.7 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $1.17 Million - $1.37 Million
-21,315 Reduced 42.94%
28,327 $1.67 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $1.08 Million - $1.58 Million
-23,358 Reduced 32.0%
49,642 $2.77 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $1.4 Million - $1.82 Million
28,367 Added 63.56%
73,000 $4.69 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $308,842 - $366,176
-7,221 Reduced 13.93%
44,633 $2.26 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $704,326 - $778,831
15,785 Added 43.76%
51,854 $2.35 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $1.4 Million - $1.67 Million
31,113 Added 627.78%
36,069 $1.72 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $347,122 - $450,134
-7,119 Reduced 58.96%
4,956 $258,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $251,611 - $283,797
4,559 Added 60.66%
12,075 $750,000
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $190,952 - $238,001
-3,779 Reduced 33.46%
7,516 $416,000
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $287,136 - $330,552
4,792 Added 73.69%
11,295 $714,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $359,160 - $414,501
6,503
6,503 $415,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.